HFA Premium Access

L-2-hydroxyglutarate dehydrogenase (L2HGDH) is a novel metabolic target protecting from cardiac hypertrophy and heart failure

Congress Presentation

About the speaker

Doctor Anca Remes

Christian-Albrechts-University Kiel, Kiel (Germany)
0 follower

11 more presentations in this session

Dual Regulation of SUMO2 and STAT1 by HectD3 Protects Heart from Hypertrophy and Inflammation

Speaker: Doctor A. Rangrez (Kiel, DE)

Thumbnail

A translational mouse model of HFpEF

Speaker: Mr A. Withaar (Groningen, NL)

Thumbnail

Diastolic dysfunction and HFpEF characteristics are exacerbated with ageing in smoothelin-like 1 (SMTNL1)-deficient mice

Speaker: Ms M. Murali (Calgary, CA)

Thumbnail

Increased granulocyte neprilysin (CD10) expression is associated with better prognosis in patients with heart failure with reduced ejection fraction

Speaker: Doctor H. Arfsten (Vienna, AT)

Thumbnail

Purified exosome product and extracellular vesicles: treatment for acute myocarditis, dilated cardiomyopathy and heart failure

Speaker: Doctor K. Bruno (Jacksonville, US)

Thumbnail

Access the full session

Rapid Fire 1 - Basic Science

Speakers: Doctor A. Remes, Doctor A. Rangrez, Mr A. Withaar, Ms M. Murali, Doctor H. Arfsten...
Thumbnail

About the event

Image

Heart Failure 2019 - 6th World Congress on Acute Heart Failure

25 May - 28 May 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk